Ex-ICMR Chief Says It Takes 18 Months To Develop Good Vaccine

Ex-ICMR chief said a good vaccine usually takes at least 18 months, before it could be rolled out for production after fast-tracking all the mandatory regulatory approvals.

N.K. Ganguly, former director general of Indian Council of Medical Research (ICMR) said a good vaccine usually takes at least 18 months, before it could be rolled out for production after fast-tracking all the mandatory regulatory approvals.

According to the government's top medical research body, a dozen institutes have been selected for clinical trials of the indigenous COVID-19 vaccine (BBV152 COVID vaccine). Ganguly said the strain of the virus was given to BBIL in May end, and in July, human trials have been scheduled.

Coronavirus
Coronaviruses infect animals, humans, and birds. Human coronaviruses, such as SARS, MERS, and 2019-nCoV cause respiratory distress and even death. The S protein is the infectious agent of the virus.

‘It is expected that India's first indigenous COVID-19 vaccine, Covaxin may be released on August 15 under a fast-track mechanism.’

Elaborating on the lengthy process involved in vaccine development, he insisted that after spending many months and infusing a lot of funds, the uncertainty continues to linger. "It may be difficult to say whether the vaccine is successful or not", he added.

The ICMR in a letter said, "It is envisaged to launch the vaccine for public health use latest by August 15, after completion of all clinical trials. BBIL (Bharat Biotech International Limited) is working expeditiously to meet the target, however the final outcome will depend on the cooperation of all clinical trial sites involved in this project."

Before the vaccine is tested on humans, challenge studies are done on mice and monkey, then a toxicology report is prepared, to check if the developed vaccine produces harm to cells, and it takes at least three to four months to finalize this report, said Ganguly. After this phase, the vaccine is tested on two rodents and a large animal and after successful completion of this stage the vaccine is ready for human trials.

Two Billion COVID-19 Vaccine Doses by Next Year: WHO
WHO has hoped that 2 billion COVID-19 vaccine doses by the end of next year. Last month, Pfizer said that it believes that a vaccine to prevent COVID-19 could be ready by the end of October.

"In Phase 1, the age group profiling is done (wherein vaccine study is done on people in different age groups). In Phase 2, nearly 600 to 700 people are vaccinated, and if the vaccine performs successfully in this phase then it progresses into Phase 3, which is called the efficacy study (in this phase, thousands of people are enrolled). Even after fast tracking regulatory approvals, it will take at least 18 months to develop a good vaccine", said Ganguly.

He insisted that the vaccine being developed by Moderna (RNA vaccine is set to begin Phase 3 trials later this month and targets a vaccine by 2021) and BioNTech-Pfizer (Phase 3 trial is expected to begin in July). Gennova biopharmaceutical is also working on a vaccine and it looks positive, Ganguly added.

COVID-19 Vaccine Development may Take 18 Months
Vaccine For COVID-19 could take at least 12-18 months to develop, according to a new report from the New York Times.

Source-IANS

WHO Hopes 2 Billion COVID-19 Vaccine Doses by 2021
Dr Soumya Swaminathan, who is the chief scientist at the World Health Organization (WHO) on Thursday, said that nearly 2 billion doses of the COVID-19 vaccine would be ready by the end of next year.